These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17514806)

  • 41. [Bleomycin combined with mitomycin C in recurrent cervix cancer].
    Tropé C; Simonsen E; Johnsson JE; Sigurdsson K
    Lakartidningen; 1982 Apr; 79(17):1689-91. PubMed ID: 6178913
    [No Abstract]   [Full Text] [Related]  

  • 42. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH; Lee C
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.
    Katz G; Hackett RL; Wajsman Z
    Urology; 1996 Jun; 47(6):928-9. PubMed ID: 8677595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.
    Xylinas E; Kent M; Dabi Y; Rieken M; Kluth LA; Al Hussein Al Awamlh B; Ouzaid I; Pycha A; Comploj E; Svatek RS; Lotan Y; Karakiewicz PI; Holmang S; Shariat SF
    Urol Oncol; 2018 Mar; 36(3):89.e1-89.e5. PubMed ID: 29221642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitomycin C reused: an in vitro cost-effectiveness study.
    Carroll PR; Williams RD; Kim MJ; Dombrovskis S
    J Urol; 1984 Sep; 132(3):583-6. PubMed ID: 6433045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superficial bladder cancer: comments on evaluation and management.
    Soloway MS
    J Urol; 1984 Jul; 132(1):91. PubMed ID: 6427488
    [No Abstract]   [Full Text] [Related]  

  • 47. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA; Van Helsdingen PJ; Kramer AE
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Results of a randomized, double blind prospective study of intravesical chemoprophylaxis with 2 drugs: adriamycin and mitomycin; and 2 ways of initiating the instillations: early and late. Effect on recurrence and progression].
    Iborra Juan I; Ricos Torrent JV; Monrós Lliso JL; Dumont Martínez R; Casanova Ramón-Borja J; Solsona Narbón E
    Arch Esp Urol; 1992 Dec; 45(10):1001-7. PubMed ID: 1294028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
    Hetherington JW; Newling DW; Robinson MR; Smith PH; Adib RS; Whelan P
    Br J Urol; 1987 Mar; 59(3):239-41. PubMed ID: 3105631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA/RNA ratio in bladder cancer: a factor indicating the recurrence rate?
    Hadjissotiriou GG; Green DK; McIntyre MA; Hargreave TB; Chisholm GD
    Br J Urol; 1985 Dec; 57(6):668-75. PubMed ID: 2417650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitomycin C for the treatment of bladder cancer.
    Volpe A; Racioppi M; D'Agostino D; Cappa E; Filianoti A; Bassi PF
    Minerva Urol Nefrol; 2010 Jun; 62(2):133-44. PubMed ID: 20562793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
    van der Meijden PM; Debruyne FM; Steerenberg PA; de Jong WH; Doesburg W
    Prog Clin Biol Res; 1989; 310():285-98. PubMed ID: 2505272
    [No Abstract]   [Full Text] [Related]  

  • 53. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).
    Parmar MK; Freedman LS; Hargreave TB; Tolley DA
    J Urol; 1989 Aug; 142(2 Pt 1):284-8. PubMed ID: 2501516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitomycin C in the treatment of superficial bladder neoplasm.
    Liberti M; De Berardinis E; Perugia G; Gentile V; Rondoni M; Riga T
    Panminerva Med; 1988; 30(1):52-3. PubMed ID: 3138624
    [No Abstract]   [Full Text] [Related]  

  • 55. Proteinuria after intravesical chemotherapy.
    Cooper EH; Yu H; Glashan RW; Robinson MR; Newling DW
    Prog Clin Biol Res; 1985; 185B():167-71. PubMed ID: 3929270
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunocytology as a possible marker to identify patients who require prophylaxis.
    Huland H; Schneider A; Huland E; Arndt R
    Prog Clin Biol Res; 1990; 350():35-9. PubMed ID: 2117288
    [No Abstract]   [Full Text] [Related]  

  • 57. [Anti-tumor effect of intravesical instillation of mitomycin C combined with cytosine arabinoside].
    Matsuda M; Matsumiya K; Tada Y; Nakano E; Fujioka H; Osafune M; Takaha M; Sonoda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1145-51. PubMed ID: 6441472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer.
    Arends TJ; van der Heijden AG; Witjes JA
    J Urol; 2014 Sep; 192(3):708-13. PubMed ID: 24704017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prophylactic intravesical instillation therapy with adriamycin (ADM) and mitomycin C (MMC) in patients with superficial bladder cancer].
    Ozaki Y; Tsushima T; Nasu Y; Akagi T; Obama T; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1493-500. PubMed ID: 3100850
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guérin instillation therapy of patients with carcinoma in situ of the bladder: a subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up.
    Järvinen R; Kaasinen E; Rintala E; Group TF
    Scand J Urol Nephrol; 2012 Dec; 46(6):411-7. PubMed ID: 22746387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.